Analytics
CDC MMWR Study—Coverage with Influenza, RSV, and COVID-19 Vaccines Among Nursing Home Residents — NHSN, November 2024
Lantana Public Health Analysts Heather Dubendris and Brynn Lape-Newman co-authored a study published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) assessing COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage for nursing home residents during the 2024-25 respiratory virus season. Learn more about the elevated risks for nursing home…
Read MoreCDC MMWR Study—Influenza, RSV, and Updated COVID-19 Vaccine Coverage Among Nursing Home Residents for December 2023
Heather Dubendris co-authored a Centers for Disease Control and Prevention (CDC) study for the Morbidity and Mortality Weekly Report (MMWR) that assessed the coverage of the COVID-19, influenza, and respiratory syncytial virus (RSV) vaccines among nursing home residents during the 2023-24 respiratory virus season.
Read MoreCDC Study Reveals Disparities in COVID-19 Vaccination Coverage
Emily Haanschoten and Heather Dubendris co-authored the study, Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents — United States, October 31, 2022–May 7, 2023 published in Morbidity and Mortality Weekly Report (MMWR). Disparities in COVID-19 vaccination coverage among Long Term Care residents based on geography and racial demographics were identified by the CDC’s…
Read MoreVital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020
Selective and Cascade Reporting of Antimicrobial Susceptibility Testing Results and Its Impact on Antimicrobial Resistance Surveillance—National Healthcare Safety Network, April 2020 to March 2021
Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status — United States, October 10, 2022–January 8, 2023
Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021
National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration Ratios
In 2019, the Centers for Disease Control and Prevention developed neonatal-specific (Standardized Antimicrobial Administration Ratios SAARs), a set of risk-adjusted antimicrobial use metrics that hospitals participating in the National Healthcare Safety Network’s (NHSN’s) antimicrobial use surveillance can use in their antibiotic stewardship programs (ASPs). This article outlines the methods and results of developing those SAARs.…
Read More